2004
Indianapolis, Ind. - Guidant Corporation (NYSE: GDT) today announced that it will participate in the Goldman Sachs 25th Annual Global Healthcare Conference on Tuesday, June 8, in Laguna Nigel, Calif.
Guidant Customers in Europe to Obtain Access to Pioneering Technology Indianapolis, Ind. and Santa Clara, Calif. - Guidant Corporation (NYSE: GDT) today announced that the company has begun...
Indianapolis, Ind. - Guidant Corporation (NYSE: GDT) today reaffirmed on the company''s mid-quarter conference call its previously stated guidance for the second quarter - sales in the range of...
MULTI-LINK MINI VISION Coronary Stent System and VOYAGER Coronary Dilatation Catheter Enable Physicians to More Easily Treat Patients with Complex Coronary Artery Disease Indianapolis, Ind. and...
Mid-Quarter Conference Call Tomorrow at 9:00 AM EDT Indianapolis, Ind. - Guidant Corporation (NYSE: GDT) will host its previously announced mid-quarter conference call tomorrow, May 27, 2004, at...
SPIRIT FIRST 30-Day and FUTURE II One-Year Results Continue to Support Benefit of Everolimus Eluting Coronary Stents Indianapolis, Ind., and Paris - Guidant Corporation (NYSE: GDT) today announced...
Evalve, Inc.''s Innovative Technology Designed to Offer New Treatment Option for Debilitating Condition Indianapolis, Ind. and Santa Clara, Calif. - Guidant Corporation (NYSE: GDT) today announced...
Trial Results Support Therapy for Extending and Improving the Lives of People with Advanced Heart Failure Indianapolis, Ind. and St. Paul, Minn. - Guidant Corporation (NYSE: GDT) today announced...
Dollens will Remain President and CEO Until His Retirement; Guido J. Neels Elevated to Chief Operating Officer Indianapolis, Ind. - Guidant Corporation (NYSE: GDT) will announce today at its...
Indianapolis, Ind. - Guidant Corporation (NYSE: GDT) today announced that the company''s board of directors declared a second quarter dividend of $0.10 per share on outstanding common stock. This...
Live Webcast Available Indianapolis, Ind. - Guidant Corporation (NYSE: GDT) today announced that it will host a mid-quarter conference call to provide an update on the company''s business. The...
Live Webcast Available Indianapolis, Ind. - Guidant Corporation (NYSE: GDT), today announced that it will participate in the Deutsche Bank Securities 29th Annual Healthcare Conference on...
Live Webcast Available Indianapolis, Ind. - Guidant Corporation (NYSE: GDT), today announced that it will participate in the Morgan Stanley Global Healthcare Unplugged Conference on Thursday, May...
Worldwide implantable defibrillator revenue of $405 million, up 22 percent. Worldwide stent revenue of $171 million, down 22 percent. Progress on drug-eluting stent programs through achievement of...
Stent Successfully Treats Patients with Difficult Coronary Blockages Indianapolis, Ind. and Santa Clara, Calif. - Guidant Corporation (NYSE: GDT) today announced Conformité Européenne (CE) Mark...
Innovative Technology Could Represent New Frontier in Treatment of Heart Disease Indianapolis, Ind. and Santa Clara, Calif. - Guidant Corporation (NYSE: GDT) today announced the $6 million...
Indianapolis - As previously announced, Guidant Corporation (NYSE: GDT) will conduct a live webcast of its first quarter 2004 earnings conference call on Thursday, April 22 at 11:00 a.m. EDT. The...
World''s Smallest, Thinnest Defibrillator Offers Advanced Rhythm Discrimination and Industry-Leading Longevity Indianapolis, IN and St. Paul, MN - Guidant Corporation (NYSE: GDT), a world leader...
Indianapolis, Ind. - Guidant Corporation (NYSE: GDT) today announced that Bernard E. Kury will join Guidant as vice president and general counsel, effective April 12. Kury will report to Ronald W....
Reflects Strength Across Major Product Lines; Company Announces Live Webcast of its First Quarter Earnings Conference Call Indianapolis, Ind. - Guidant Corporation (NYSE: GDT) today announced...
Everolimus Eluting Stent Trial Will Provide Additional Safety and Performance Data Indianapolis, Ind. and Santa Clara, Calif. - Guidant Corporation (NYSE: GDT) today announced that the first...
Important Milestone Achieved in Guidant''s Everolimus Eluting Stent Program; Next-Generation Drug Eluting Stent Utilizes Company''s VISION Cobalt Chromium Stent Technology Indianapolis, Ind., and...
Results Will Broaden Patient Population Who Clearly Benefit from an Implantable Defibrillator Indianapolis, Ind. and St. Paul, Minn. - Guidant Corporation (NYSE: GDT), a world leader in the...